C
Concord Drugs
81.00
BSE
C
Concord Drugs
81.00
BSE
CONCORD Fundamentals
Company Valuation
Market Cap (₹ Cr.)
107
PE Ratio
189.60
PB Ratio
2.34
Dividend Yield
-
ROE
0.99%
ROCE
6.98%
Book Value (₹)
34.87
Face Value (₹)
10.00
Analyse CONCORD with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Jun 2025 | Sep 2025 | Nov 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 54.39% | 54.39% | 45.08% | 54.39% | 54.39% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 42.57% | 44.95% | 54.43% | 44.96% | 44.66% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
CONCORD Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
538965
NSE Scrip Name
CONCORD
ISIN
INE858L01010



